InnovAge Holding Corp.
Close on Oct 19, 2026
- Market cap
- $1.21B
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 3, 2026, during market hours (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q4 FY2026 Ended Jun 30, 2026 | Sep 8, 2026 | During market hours | $261.95M | $0.06 | – |
| Q3 FY2026 Ended Mar 31, 2026 | May 5, 2026 | During market hours | $251.90M | $-0.22 | – |
| Q2 FY2026 Ended Dec 31, 2025 | Feb 3, 2026 | During market hours | $239.70M | $0.08 | – |
| Q1 FY2026 Ended Sep 30, 2025 | Nov 4, 2025 | During market hours | $236.10M | $0.06 | – |
| Q4 FY2025 Ended Jun 30, 2025 | Sep 9, 2025 | During market hours | $221.42M | $-0.01 | – |
| Q3 FY2025 Ended Mar 31, 2025 | May 6, 2025 | During market hours | $218.14M | $-0.08 | – |
| Q2 FY2025 Ended Dec 31, 2024 | Feb 4, 2025 | During market hours | $209.00M | $-0.10 | – |
| Q1 FY2025 Ended Sep 30, 2024 | Nov 5, 2024 | During market hours | $205.10M | $-0.04 | – |
| Q4 FY2024 Ended Jun 30, 2024 | Sep 10, 2024 | During market hours | – | – | – |
| Q3 FY2024 Ended Mar 31, 2024 | May 7, 2024 | During market hours | – | – | – |
| Q2 FY2024 Ended Dec 31, 2023 | Feb 6, 2024 | During market hours | – | – | – |
Company guidance
Outlook given with results on Sep 8, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Adjusted EBITDAnon-GAAP | Full Fiscal Year 2027 | $105.00M to $115.00M | New |
| Census | Full Fiscal Year 2027 | 8,625 to 8,850 | New |
| Total Member Months | Full Fiscal Year 2027 | 101,000 to 102,500 | Raised |
| Total revenues | Full Fiscal Year 2027 | $1.05B to $1.09B | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements InnovAge filed with the SEC
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
InnovAge Appoints Jennifer Browne as President and Chief Operating Officer
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
InnovAge Expands Board with Appointment of Two Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
JPM Healthcare Conference January 2026 d
Regulation FD disclosure · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
InnovAge Appoints Michael Scarbrough as New President and Chief Operating Officer and Maria Lozzano as President, Pharmacy Services
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
INNOVAGE HOLDING CORP. ANNOUNCES INCREASE OF
Other events · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
$5.0 MILLION SHARE REPURCHASE PROGRAM
Other events · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
2024 Investor Day February 2024 d
Regulation FD disclosure · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
InnovAge Strengthens Board with Appointment
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
InnovAge Names Ben Adams as New Chief
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
Removed at InnovAge Sacramento PACE Center Enabling New Participant Enrollment
Regulation FD disclosure · EX-99.1 to Form 8-K
InnovAge Diversifies Board of Directors
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
InnovAge Names Christine Bent as Chief Operations
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
Regulators Lift Sanctions at InnovAge’s Colorado PACE Centers
Regulation FD disclosure · EX-99.1 to Form 8-K
InnovAge Announces Release of CMS Sanction in
Regulation FD disclosure · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
InnovAge Appoints James Carlson to the Board as Non-Executive Chairman
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES FINANCIAL RESULTS FOR THE
Results of operations · EX-99.1 to Form 8-K
INNOVAGE ANNOUNCES THE RESIGNATION OF CEO MAUREEN
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
InnovAge Announces Audit Sanctions In Colorado
Other events · EX-99.1 to Form 8-K